Sildenafil Citrate Research Overview
Viagra DP Dragon Pharma contains sildenafil citrate, a phosphodiesterase type 5 (PDE5) inhibitor originally developed for cardiovascular research. This compound selectively inhibits the PDE5 enzyme, which degrades cyclic guanosine monophosphate (cGMP) in smooth muscle cells. Through this mechanism, sildenafil citrate modulates nitric oxide signalling pathways and has become a valuable tool for researchers investigating vascular biology, endothelial function, and cyclic nucleotide metabolism. The research applications of this well-characterised compound extend across multiple therapeutic areas, making it an important reference standard for in-vitro studies examining cardiovascular physiology and molecular pharmacology.
Laboratory Applications for PDE5 Research
Research laboratories utilise sildenafil citrate to examine PDE5 enzyme kinetics, nitric oxide pathway modulation, and cyclic nucleotide signalling cascades. Studies have investigated this compound’s effects on pulmonary arterial pressure, endothelial cell function, and smooth muscle relaxation mechanisms in various experimental models. Researchers at Stroid UK Shop can access this pharmaceutical-grade compound for investigating cardiovascular research questions. The selective PDE5 inhibition properties make it suitable for examining adenylyl cyclase pathways and guanylyl cyclase regulation. Additionally, scientists studying SARMs interactions or peptides research may incorporate sildenafil citrate as a positive control when examining vascular responses. This erection drug research category provides essential tools for comprehensive cardiovascular studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sildenafil Citrate |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.70 g/mol |
| Manufacturer | Dragon Pharma |
| Storage Conditions | Room temperature, dry environment |
| Solubility | Water soluble as citrate salt |
| Research Applications | PDE5 inhibition studies, cardiovascular research |
Research Compliance Statement
Viagra DP Dragon Pharma is manufactured exclusively for in-vitro laboratory research applications and scientific investigation. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory protocols, adequate ventilation, and appropriate safety measures when handling this compound. All studies should comply with institutional review board guidelines and applicable research regulations. Purchase and use of this product acknowledges understanding that it is restricted to qualified research facilities conducting legitimate scientific investigations into PDE5 enzyme function and cardiovascular biology mechanisms.
